Big Pharmas maintain pause of Twitter ads, spending drops to zero for first week of 2023
The new year is a time for new resolutions, but for pharma marketers a 2022 resolve to pause Twitter ad spending remains in place. The first week of 2023 showed $0 spent among a group of about 20 leading pharma advertisers on Twitter, according to spending data tabulated by Pathmatics for Endpoints News.
Last week’s Twitter spending drop to zero comes on the heels of minimal spending by pharma companies in December, according to Pathmatics. AstraZeneca, GSK and Sanofi spent small amounts on ads last month, although none of the three totaled more than $12,000 for all of December.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
